- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 802.07M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 719.83M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $57K |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $155K |
| Capex | Q1 2025 · Mar 31, 2025 | $47K |
| Capex | Q1 2025 · Mar 31, 2024 | $106K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$1.74M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$886K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $18.77M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $26.64M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $33.77M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $47.46M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $59.25M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $58.69M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $23.03M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $23.59M |
| Current Liabilities restated | Q1 2025 · Mar 31, 2024 | $23.91M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $24.21M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $24.71M |
| Total Liabilities restated | Q1 2025 · Mar 31, 2024 | $24M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $31.32M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $43.94M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $57M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $69.47M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.00 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $2.9M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.4M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $5.76M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.46M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$818K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$3.1M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$974K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.43M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $13.41M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $10.71M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $4.59M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $3.32M |
| Revenue | Q1 2025 · Mar 31, 2025 | $18M |
| Revenue | Q1 2025 · Mar 31, 2024 | $14.02M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $4.98M |